Aug 7, 2020 | Health, Innovation
COVID-19 has forced most of the world to work remotely, causing a major disruption in clinical research and the drug development process. As a result, the need for centralized and advanced patient engagement technology to better healthcare for all parties involved,...
Jul 22, 2020 | News, Regulatory
The US government will pay American pharmaceutical leader Pfizer and German biotech BioNTech $1.95 billion USD to buy enough COVID-19 vaccines for approximately 50 million people. Pfizer and BioNTech will not receive payment until their...
Jan 21, 2020 | News, Regulatory
Beginning of Changes China revised its pharmaceutical regulations by releasing the second draft of the Drug Administration Law of the People’s Republic of China (DAL) to the Committee of the National People’s Congress of China (NPC) for discussion. The...
May 4, 2017 | Pharmaceuticals
Blog Post Content This week I want to delve into the unique challenges of translations in the pharmaceutical industry. As with all medical translations, the biggest challenges often come from the difficult nature of industry specific terminology. The pharmaceutical...
